Summit Trail Advisors’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-15,467
Closed -$293K – 1355
2025
Q3
$293K Sell
15,467
-806
-5% -$13.3K ﹤0.01% 1214
2025
Q2
$349K Buy
+16,273
New +$242K 0.01% 865
2024
Q4
– Sell
-15,888
Closed -$337K – 651
2024
Q3
$337K Sell
15,888
-4,932
-24% -$88.8K 0.01% 511
2024
Q2
$329K Buy
20,820
+1,065
+5% +$19.6K 0.01% 463
2024
Q1
$294K Buy
19,755
+1,715
+10% +$23.5K 0.01% 468
2023
Q4
$165K Buy
18,040
+608
+3% +$4.2K 0.01% 514
2023
Q3
$97.1K Buy
17,432
+295
+2% +$2.06K ﹤0.01% 524
2023
Q2
$138K Buy
+17,137
New +$126K 0.01% 510
2023
Q1
– Sell
-16,162
Closed -$39.8K – 431
2022
Q4
$39.8K Hold
16,162
– – ﹤0.01% 399
2022
Q3
$81K Hold
16,162
– – ﹤0.01% 367
2022
Q2
$69K Buy
+16,162
New +$103K ﹤0.01% 374

Other funds holding OSCR

Summit Trail Advisors's OSCR Position: Q4 2025 in Review

Summit Trail Advisors sold out of Oscar Health (OSCR) in Q4 2025, closing a stake of 15,467 shares — an estimated $293K sold.

Summit Trail Advisors first reported a position in OSCR in Q2 2022 and held it in 11 quarters. The position peaked at $349K in Q2 2025. 343 funds tracked by Wall St. Rank hold OSCR as of Q4 2025.

  • Summit Trail Advisors reported no remaining Oscar Health position as of Q4 2025 after selling out during the quarter.
  • Summit Trail Advisors sold 15,467 Oscar Health shares in Q4 2025, an estimated $293K.
  • Summit Trail Advisors first reported a position in Oscar Health in Q2 2022 and held it in 11 quarters.
  • Summit Trail Advisors's Oscar Health position peaked at $349K in Q2 2025.
  • 343 funds tracked by Wall St. Rank held Oscar Health as of Q4 2025.

Based on Summit Trail Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.